Generic Name and Formulations:
Malathion 0.5%; lotion; contains alcohol 78%.
Indications for OVIDE:
Adults and Children:
<6yrs: not recommended. ≥6yrs: apply to dry hair until hair and scalp are thoroughly wet. Let hair dry naturally (do not use blow dryer or other heat source). Shampoo and rinse after 8–12 hours; remove dead lice and eggs with nit comb. May repeat once after 7–9 days. Wash hands after application. Wash or dryclean bedding or clothing appropriately.
For use on scalp only. Remove if irritation occurs, may reapply if irritation subsides; discontinue if irritation recurs. Avoid eyes. Product is flammable; keep away from heat and flame (including smoking, hair dryers, electric curlers). Pregnancy (Cat.B). Nursing mothers.
Stinging, irritation, mild conjunctivitis.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|